Read More
Suven Life Sciences Achieves 100% Patient Enrolment for MDD Phase-2b Trial ...
The stock is up over 70 per cent from its 52-week low of Rs 102.70 per share with multibagger return...
Articles of DSIJ%20Artilcle
The stock is up over 70 per cent from its 52-week low of Rs 102.70 per share with multibagger return...
Copyright 2025 by DSIJ Wealth Advisory Pvt. Ltd. (Formerly Known as DSIJ Pvt. Ltd.)